Pyrimidines as novel openers of potassium ion channels

Details Pyrimidines as novel openers of potassium ion channels Pyrimidines as novel openers of potassium ion channels

2007-04-17

2007-04-17

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S322000, C544S324000, C544S300000, C544S301000, C544S309000, C544S310000, C544S316000, C544S319000

Reexamination Certificate

active

10305706

ABSTRACT:
The present invention provides a genus of pyrimidine amides that are useful as openers of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.

REFERENCES:
patent: 4980355 (1990-12-01), Zondler et al.
patent: 5811428 (1998-09-01), Suto et al.
patent: 5849789 (1998-12-01), Rostock et al.
patent: 5852053 (1998-12-01), Rostock et al.
patent: 6372767 (2002-04-01), McNaughton-Smith et al.
patent: 6469042 (2002-10-01), Hewawasam et al.
patent: 0 554 543 (1996-02-01), None
patent: WO 97/09315 (1997-03-01), None
patent: WO-99041231 (1999-08-01), None
patent: WO 00/46203 (2000-08-01), None
patent: WO 01/02354 (2001-01-01), None
patent: WO 01/49685 (2001-07-01), None
patent: WO 02/066036 (2002-08-01), None
patent: WO 02/072088 (2002-09-01), None
patent: WO-02070483 (2002-09-01), None
patent: WO 02/096858 (2002-12-01), None
patent: WO-02098363 (2002-12-01), None
patent: WO-03037274 (2003-05-01), None
patent: WO-03068769 (2003-08-01), None
Mulley et al. Curr. Opin. Neurol., 16(2): 171-176, 2003.
Jensen BS CNS Drug Rev. 8(4): 353-360, 2002.
Hashimoto et al. Chemical & Pharmaceutical Bulletin, 48(10). 1504-1513, 2000.
Pie et al. Synthesis 7, 838-842, 1996.
Machon et al. Polish Journal of Pharmacology and Pharmacy 28(1), 6-67, 1976.
Gloria, T.S., Revista de Farmacia e Bioquimica da Universidade de Sao Paulo 9(1) 193-199, 1971.
Wilczynska et al. Chemik, 18, 28-29, 1965.
Wickenden et al., Expert. Opin. Ther. Patents 14(4); 1-12, 2004 . .
Avramopoulos, D. et al.; “Linkage of bipolar affective disorder on chromosome 8q24: follow-up and parametric analysis”;Molecular Psychiatry;2004; pp. 191-196; vol. 9, No. 2.
Browne, D. L. et al.; “Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1”;Nature Genetics;1994; pp. 136-140; vol. 8, No. 2.
Cooper, E. C. et al.; “Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy”;Proc. Natl. Acad. Sci. USA;2000; pp. 4914-4919; vol. 97, No. 9.
Cooper, E. C. et al.; “M Channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain”;The Journal of Neuroscience,2001; pp. 9529-9540; vol. 21.
Dedek, K. et al.; “Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel”;Proc. Natl. Acad. Sci. USA;2001; pp. 12272-12277; vol. 98, No. 21.
Dedek et al., Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.Proc Natl Acad Sci U S A.(2001) 98(21):12272-7.
Goadsby P. J. et al.; “Migraine—current understanding and treatment”;N. Engl. J. Med.;Jan. 24, 2002; pp. 257-270; vol. 346, No. 4.
Ilyin, V. I. et al.; “Flupirtine—A positive modulator of heteromeric KCNQ2/Q3 channels”;Soc. Neurosci. Abstract;Program No. 758. 10; 2002; Online Available Web Site: http://sfn.scholarone.com/itin2002/index.html Accessed on Feb. 28, 2004.
Kubisch, C. et al.; “KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness”;Cell;1999; pp. 437-446; vol. 96.
Saganich, M. J. et al.; “Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain”;The Journal of Neuroscience;2001; pp. 4609-4624; vol. 21.
Schuster, G. et al.; “Flupirtine: A review of its neuroprotective and behavioural properties”;CNS Drug Reviews;1998; pp. 149-164; vol. 4.
Smith J. S. et al.; “Differential expression of KCNQ2 splice variants: implications to M current function during neuronal development”;The Journal of Neuroscience;2001; pp. 1096-1103; vol. 21, No. 4.
Falco, Elvira A., et al. “Studies on Condensed Pyrimidine Systems. X. Some 1,3-Oxazolo (5,4-d)pyrimidines”,Journal of the American Chemical Society,(1952) 74(19):4897-4902.

Affiliated with

Also associated with

Rating

Pyrimidines as novel openers of potassium ion channels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidines as novel openers of potassium ion channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidines as novel openers of potassium ion channels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3756749